Scilex Holding (SCLX) Goodwill & Intangibles (2021 - 2026)
Scilex Holding (SCLX) posted quarterly Goodwill & Intangibles of $73.3 million for Q1 2026, up 63.11% year-over-year from $44.9 million in Q1 2025, and up 0.99% quarter-over-quarter from $72.6 million in Q4 2025.
Scilex Holding (SCLX) Goodwill & Intangibles (2021 - 2026) Analysis & Trends
Scilex Holding's Goodwill & Intangibles history runs 6 years deep, the most recent figure standing at $73.3 million for Q1 2026.
- In Q1 2026, Goodwill & Intangibles rose 63.11% year-over-year to $73.3 million; the TTM figure through Mar 2026 stood at $73.3 million (up 63.11% YoY), while the FY2025 annual figure was $72.6 million, up 57.92% from the prior year.
- Goodwill & Intangibles for Q1 2026 stood at $73.3 million, up from $72.6 million in the prior quarter.
- The five-year high for Goodwill & Intangibles was $75.3 million in Q3 2025, with the low at $5.0 million in Q1 2022.
- The 5-year median for Goodwill & Intangibles is $74.3 million (2022), against an average of $57.1 million.
- The sharpest annual moves came in 2023 and 2024: Goodwill & Intangibles soared 1385.62% in 2023, then plunged 38.14% in 2024.
- Scilex Holding's Goodwill & Intangibles stood at $74.3 million in 2022, then advanced by 0.03% to $74.3 million in 2023, then slumped by 38.14% to $46.0 million in 2024, then surged by 57.92% to $72.6 million in 2025, then climbed by 0.99% to $73.3 million in 2026.
- Business Quant data shows SCLX's Goodwill & Intangibles at $73.3 million in Q1 2026, $72.6 million in Q4 2025, and $75.3 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 652.20 Bn | 631.44 Bn | 17.26 Bn |
| 2 | AbbVie | 469.51 Bn | 462.94 Bn | 12.70 Bn |
| 3 | Merck | 376.81 Bn | 369.67 Bn | 12.21 Bn |
| 4 | Novartis Ag | 303.04 Bn | 295.35 Bn | 11.24 Bn |
| 5 | Astrazeneca | 257.61 Bn | 252.71 Bn | 12.86 Bn |
| 6 | Amgen | 237.37 Bn | 223.38 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 181.73 Bn | 178.55 Bn | 6.22 Bn |
| 8 | Pfizer | 159.66 Bn | 147.96 Bn | 10.94 Bn |
| 9 | Gsk | 106.24 Bn | 102.07 Bn | 8.24 Bn |
| 10 | Scilex Holding | 39.22 Mn | -73.57 Mn | 3.97 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 73.29 Mn |
| Dec 31, 2025 | 72.57 Mn |
| Sep 30, 2025 | 75.28 Mn |
| Jun 30, 2025 | 75.26 Mn |
| Mar 31, 2025 | 44.93 Mn |
| Dec 31, 2024 | 45.95 Mn |
| Sep 30, 2024 | 74.26 Mn |
| Jun 30, 2024 | 74.28 Mn |
| Mar 31, 2024 | 48.94 Mn |
| Dec 31, 2023 | 74.28 Mn |
| Sep 30, 2023 | 74.28 Mn |
| Jun 30, 2023 | 74.28 Mn |
| Mar 31, 2023 | 74.26 Mn |
| Dec 31, 2022 | 74.26 Mn |
| Sep 30, 2022 | 5.00 Mn |
| Jun 30, 2022 | 5.00 Mn |
| Mar 31, 2022 | 5.00 Mn |
| Dec 31, 2021 | 52.28 Mn |